Click here for the latest DSCSA updates, including the FDA's decision to delay enforcement and set several new 2025 deadlines.
By Heidi Splete
Requests for waivers, exceptions and exemptions (WEEs) for the Drug Supply Chain Security Act (DSCSA) are more likely to succeed if applicants not only explain clearly why they are needed, but also what they are doing to achieve compliance and maintain supply chain security in the meantime, according to a panel of experts in a presentation at